Clinical Trial Update: URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for URO-902 in women with overactive bladder and urge urinary incontinence has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder with Urge Urinary Incontinence

Drugs mentioned

• URO-902

Snippet

Sponsor: Urovant Sciences GmbH | Conditions: Overactive Bladder With Urge Urinary Incontinence | Phase 2 | Status: COMPLETED | Results posted: 2023-04-20